Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Dr. Chandrkant Shah as Independent Director with effect from 19th July,2023.19-07-2023
19-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Management
1. Appointment of Ms. Niharika Agarwal as an Additional Director in the category of Independent Director on the Board of the Company. 2. Resignation of Dr. Chandrakant Shah as Independent Director with effect from 19th July,2023.19-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Results For Quarter Ended 30Th June, 2023
un-audited financial results of the Company for th quarter ended 30th June, 2023 along with limited review report19-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Held On 19Th July, 2023
1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2023 along with the Limited Review Report as issued by M/s. R.H Nisar & Co, Statutory Auditors of the Company; copies of which are attached hereunder; 2. Appointment of Ms. Niharika Agarwal (DIN: 10192397) as an Additional Director of the Company in the category of Independent Director for a term of 5 years w.e.f. 19th July, 2023, subject to the approval of members at the ensuing Annual General Meeting of the Company. A brief profile of Ms. Niharika Agarwal is enclosed as 'Annexure A'. 3. Resignation of Dr. Chandrakant Shah (DIN: 02843653) as Independent Director with effect from 19th July, 2023.19-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Discussing, Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2023
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2023 ,inter alia, to consider and approve unaudited Financial Results of the Company for the Quarter Ended 30th June 2023 and any other matter with the permission of the Chair.11-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Compliances- Statement Of Deviation Or Variation In The Use Of Proceeds Of Preferential Issue.
Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015 we hereby confirm that there is no deviation or variation in use of proceeds from objects stated in the Explanatory Statement to the Notice of EOGM of the Company dated August 27, 2022.07-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance to Regulation 74(5) of SEBI ( Depositories and Participants ) Regulations, 2018; we furnish hereunder Certificate dated July 01, 2023 received from the SEBI Registered Registrar and Share Transfer Agent ( RTA ) viz. Purva Sharegistry ( India ) Pvt. Ltd for the quarter ended June 30, 202306-07-2023
Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015, and "Code of Conduct for Prevention of Insider Trading" of Fredun Pharmaceuticals Limited(hereinafter referred to as the company), the trading window for dealing in securities of the company will remain closed for designated persons and their immediate relatives with effect fron Saturday, 01st July,2023 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the quarter ended 30th June,2023, would be considered, approved and declared.The said information is being notified to all designated persons under the above Regulations29-06-2023
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find herewith enclosed the Annual Secretarial Compliance Report of the Company for the year ended March 31, 2022, as issued by Ms. Kala Agarwal, Practicing Company Secretaries on 19th June,2023.19-06-2023
Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 14th June, 2023 from Purva Sharegistry (India) Pvt. Ltd, the Share Transfer Agent of the Company, pertaining to loss/ misplacement of Original Share Certificate(s) and have requested for issuance of Duplicate Share Certificate(s); in lieu of their Original Share Certificates been lost.15-06-2023